Cantel Medical Corporation
CMD
CMD was delisted on the 1st of June, 2021.
244 hedge funds and large institutions have $2.99B invested in Cantel Medical Corporation in 2019 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 81 increasing their positions, 82 reducing their positions, and 26 closing their positions.
8% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 26
1% more funds holding
Funds holding: 242 → 244 (+2)
1% less repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 82
5% less capital invested
Capital invested by funds: $3.13B → $2.99B (-$145M)
9% less call options, than puts
Call options by funds: $5.59M | Put options by funds: $6.11M
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
+$50.4M |
| 2 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$38.9M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$8.61M |
| 4 |
Millennium Management
New York
|
+$8.47M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$8.35M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
-$26.4M |
| 2 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
-$21.4M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$12.1M |
| 4 |
State Street
Boston,
Massachusetts
|
-$6.24M |
| 5 |
BlackRock
New York
|
-$4.61M |
CMD Hedge Fund Activity: Q3 2019 in Review
244 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Cantel Medical Corporation (CMD) for Q3 2019, worth a combined $2.99B — down 4.6% from $3.13B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new CMD positions and 26 closed out — a net gain of 2 holders — while 81 added to existing stakes and 82 trimmed.
The largest buyer was Fred Alger Management, adding an estimated $50.4M. The largest seller was Mackenzie Financial, cutting an estimated $26.4M.
- 244 institutional investors held Cantel Medical Corporation (CMD) as of Q3 2019, up from 242 in Q2 2019.
- Funds reported $2.99B of Cantel Medical Corporation stock for Q3 2019, down 4.6% quarter-over-quarter.
- 28 funds opened new Cantel Medical Corporation positions in Q3 2019 and 26 closed out, a net change of +2 holders.
- The largest Cantel Medical Corporation buyer in Q3 2019 was Fred Alger Management, an estimated $50.4M added.
- The largest Cantel Medical Corporation seller in Q3 2019 was Mackenzie Financial, an estimated $26.4M sold.
Based on aggregated 13F filings for Q3 2019.